Furthermore, apelin-13 administration ameliorated STZ-induced AD-like phenotypes, suggesting that enhancement of hippocampal apelin/APJ signaling may indicate a new treatment approach to AD. The gene discussed is APLNR; the disease is Alzheimer disease.